First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.49 USD 6.9% Market Closed
Updated: Mar 29, 2024

ADC Therapeutics SA
Free Cash Flow

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

ADC Therapeutics SA
Free Cash Flow Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Free Cash Flow
$-139.1m
CAGR 3-Years
7%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Free Cash Flow
CHf-61.2m
CAGR 3-Years
0%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Free Cash Flow
$-272.3m
CAGR 3-Years
-2%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Free Cash Flow
CHf13.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Idorsia Ltd
SIX:IDIA
Free Cash Flow
CHf-886.2m
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Free Cash Flow
CHf-7.7m
CAGR 3-Years
9%
CAGR 5-Years
12%
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Free Cash Flow?
Free Cash Flow
-139.1m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Free Cash Flow amounts to -139.1m USD.

What is ADC Therapeutics SA's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-2%

Over the last year, the Free Cash Flow growth was 0%. The average annual Free Cash Flow growth rates for ADC Therapeutics SA have been 7% over the past three years , -2% over the past five years .